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Commercial silicate-based bioglasses, including 45S5 glass have been
subject of vast interest in the biomedical ﬁeld for many years [1]. Sev-
eral limitations of those commercial glasses, such as: limited degrada-
bility, low porosity and it generates an acidic medium that induce
inﬂammatory response led to the development of silica-borate glass sys-
tems for biomedical applications [2-5]. Silica-borate systems can over-
come some of the enumerated drawbacks, when used as part of
composite systems. They can improve the strength of the composite
through the reaction of the glass degradation products (e.g. cartions)
with the polymeric matrices. Additionally, controlling the degradation
it is possible to increase the porosity of composites.
The main objective of this work was to prepare silica-borate glass
compositions by melt quenching. Glass compositions of general formula
0.20B2O3:0.40SiO2:xMgO:yCaO: (0.35-x-y)SrO:0.05Na2O (molar
ratio, where x, y = 0.35 or 0.00, and x 6¼ y) were synthesised, and com-
posite ﬁbres were prepared by wet spinning of a PLA solution contain-
ing a suspension of the glass particles. Fibre meshes of the processed
ﬁbres were prepared and their cytotoxicity was evaluated by direct con-
tact with human osteosarcoma cell line Saos-2, throughout 7 days of
incubation (37 °C and 5% CO2 atmosphere). For day 1, 3 and 7, cell
proliferation (DNA quantiﬁcation method) and metabolic activity (MTS
method) were monitored. Additionally, it was tested the water uptake
and weight loss of the developed systems, as well as their capacity to
form a calcium phosphate layer when immersed in simulated body
ﬂuid (SBF).
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Glycosaminoglycans (GAGs) are integral part of the closest cellular
environment: they can be found on the cells surface and in the extracel-
lular matrix, where they interact with different proteins acting as local
regulator of their activity. The use of GAGs in the preparation of protein
delivery nanosystems is, therefore, prominent but so far, underexploited
mainly because of the heterogeneity (composition and molecular
weights) of natural glycans and the multistep procedures needed to
obtain GAGs’ synthetic analogues and diblock copolymers.1 Recently,
we have shown that oxime click reaction can be applied as a straightfor-
ward methodology for the synthesis of poly(ethylene glycol) (PEG)-
hyaluronic acid (HA) diblock copolymers.2 These copolymers formed
nanosized interpolyelectrolyte complexes (45 to 150 nm) by interaction
with poly- L -lysine (PLL).3 Unfortunately, these complexes are not sta-
ble at physiological ionic strength. Herein, we describe a strategy to
overcome this drawback; chondroitin sulphate-b-PEG diblock copoly-
mers (CS-b-PEG) were obtained using the same oxime click reaction.
The stronger negative charge of sulphate groups (versus the carboxilic
groups present in HA) resulted in the complexes with higher stability:
interpolyelectrolyte complexes between PLL and (CS-b-PEG) are stable
up to 260 mM ionic strenght. Because carbohydrates do not activate T-
cells, we believe that the reported herein complexes have an enormous
potential in both drug delivery and vaccination ﬁelds.4
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